Back to Search
Start Over
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
- Source :
-
Journal of hepatology [J Hepatol] 2014 Feb; Vol. 60 (2), pp. 290-7. Date of Electronic Publication: 2013 Oct 23. - Publication Year :
- 2014
-
Abstract
- Background & Aims: The current organ allocation system for liver transplantation (LT) creates an imbalance between patients with and without hepatocellular carcinoma (HCC). We describe a model designed to re-establish allocation equity among patient groups using transplant benefit as the common endpoint.<br />Methods: We enrolled consecutive adult patients entering the waiting list (WL group, n=2697) and undergoing LT (LT group, n=1702) during the period 2004-2009 in the North Italy Transplant program area. Independent multivariable regressions (WL and LT models) were created for patients without HCC and for those with stage T2 HCC. Monte Carlo simulation was used to create distributions of transplant benefit, and covariates such as Model for End-stage Liver Disease (MELD) and alpha-fetoprotein (AFP) were combined in regression equations. These equations were then calibrated to create an "MELD equivalent" which matches HCC patients to non-HCC patients having the same numerical MELD score.<br />Results: Median 5 year transplant benefit was 15.12 months (8.75-25.35) for the non-HCC patients, and 28.18 months (15.11-36.38) for the T2-HCC patients (p<0.001). Independent predictors of transplant benefit were MELD score (estimate=0.89, p<0.001) among non-HCC patients, and MELD (estimate=1.14, p<0.001) and logAFP (estimate=-0.46, p<0.001) among HCC patients. The equation "HCC-MELD"=1.27∗MELD - 0.51∗logAFP+4.59 calculates a numerical score for HCC patients, whereby their transplant benefit is equal to that of non-HCC patients with the same numerical value for MELD.<br />Conclusions: We describe a method for calibrating HCC and non-HCC patients according to survival benefit, and propose that this method has the potential, if externally validated, to restore equity to the organ allocation system.<br /> (Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Adult
Carcinoma, Hepatocellular mortality
End Stage Liver Disease mortality
Female
Humans
Italy epidemiology
Liver Neoplasms mortality
Male
Markov Chains
Middle Aged
Monte Carlo Method
Proportional Hazards Models
Severity of Illness Index
Tissue and Organ Procurement statistics & numerical data
Carcinoma, Hepatocellular complications
Carcinoma, Hepatocellular surgery
End Stage Liver Disease complications
End Stage Liver Disease surgery
Liver Neoplasms complications
Liver Neoplasms surgery
Liver Transplantation
Tissue and Organ Procurement methods
Waiting Lists
Subjects
Details
- Language :
- English
- ISSN :
- 1600-0641
- Volume :
- 60
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of hepatology
- Publication Type :
- Academic Journal
- Accession number :
- 24161408
- Full Text :
- https://doi.org/10.1016/j.jhep.2013.10.010